ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Programs: NCI To Study Colorectal Cancer Screening Practices

September 17, 1999

Harkin, Hatfield Propose Trust Fund to Raise Research Funding

May 28, 1993

Movement To Resolve Patient Care Reimbursement Problems Gains Momentum; NCI Report Adds Fuel

March 17, 1989

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003